| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.39 | 0.06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |